|
Delayed
OTC Markets
23:06:37 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| 12-29 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 21/10/25 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Business description: Seelos Therapeutics, Inc.
Number of employees: 8
Sales by Activity: Seelos Therapeutics, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) |
|---|---|---|---|---|---|
Pharmaceuticals | 375K | - | - | - | 2.2M |
Geographical breakdown of sales: Seelos Therapeutics, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) |
|---|---|---|---|---|---|
United States | 375K | - | - | - | 2.2M |
Executive Committee: Seelos Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 66 | 01/01/2019 |
| Director of Finance/CFO | 54 | 01/09/2021 | |
Gopal Krishna
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anthony Marciano
IRC | Investor Relations Contact | - | 01/01/2019 |
Company details: Seelos Therapeutics, Inc.
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 1 | |
| +0.34% | +1.12% | +34.75% | +61.06% | 64.38B | |
| +0.42% | +3.68% | +15.46% | +85.41% | 56.16B | |
| +0.87% | +2.28% | +15.72% | +107.45% | 54.16B | |
| -2.06% | -3.20% | +24.93% | +52.65% | 45.33B | |
| +0.01% | -2.01% | +20.05% | +98.29% | 42.25B | |
| -1.03% | +0.48% | +219.14% | +923.87% | 40.78B | |
| +1.69% | +46.03% | +109.89% | +93.92% | 33.8B | |
| -0.26% | -2.57% | +12.55% | +45.18% | 32.25B | |
| -1.29% | -2.88% | +21.60% | -11.92% | 23.57B | |
| Average | -0.13% | +3.85% | +52.68% | +161.77% | 39.27B | |
| Weighted average by Cap. | -0.04% | +3.36% | +49.66% | +160.73% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SEELQ Stock
- Company Seelos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
